Team:Paris/August 26
From 2008.igem.org
(→Results of the electrophoresis) |
|||
(7 intermediate revisions not shown) | |||
Line 3: | Line 3: | ||
=Extraction of EnvZ* and OmpR* from ''E. coli'' genome= | =Extraction of EnvZ* and OmpR* from ''E. coli'' genome= | ||
==Name of the PCR== | ==Name of the PCR== | ||
- | {|border="2" | + | {|style="text-align: center;" border="2" |
|Name | |Name | ||
|What's in ? | |What's in ? | ||
Line 34: | Line 34: | ||
|O 139 | |O 139 | ||
|} | |} | ||
+ | |||
==Protocol== | ==Protocol== | ||
Line 103: | Line 104: | ||
==PCR Promoters FlhDC and Gene== | ==PCR Promoters FlhDC and Gene== | ||
- | * pFlhDC (O111-F / O113-R) | + | * PCR 137 = pFlhDC (O111-F / O113-R) |
- | * Gene FlhDC (O134-F / O131-R) | + | * PCR 141 = Gene FlhDC (O134-F / O131-R) |
- | * pFlgB (O102-F / O103-R) | + | * PCR 125 = pFlgB (O102-F / O103-R) |
- | * pFlhB (O108-F / O109-R) | + | * PCR 126 = pFlhB (O108-F / O109-R) |
---- | ---- | ||
Line 167: | Line 168: | ||
==PCR mutagenesis FliA== | ==PCR mutagenesis FliA== | ||
- | * PCRFliA1 (O143-F / O152-R) | + | * PCRFliA1 (O143-F / O152-R) |
- | * PCRFliA2 (O153-F / O150-R) | + | * PCR 145 = PCRFliA1' (O148-F / O152-R) |
+ | * PCR 146 = PCRFliA2 (O153-F / O150-R) | ||
* PCRFliA3 (O148-F / O150-R) | * PCRFliA3 (O148-F / O150-R) | ||
Line 277: | Line 279: | ||
|style="background: #cbff7B"| ~ 1000 bp | |style="background: #cbff7B"| ~ 1000 bp | ||
|} | |} | ||
+ | |||
=Cloning of EnvZ*= | =Cloning of EnvZ*= | ||
Line 283: | Line 286: | ||
{|border="1" style="text-align:center" | {|border="1" style="text-align:center" | ||
- | |||
|'''Digestion n°''' | |'''Digestion n°''' | ||
+ | |'''Name''' | ||
|'''[DNA] in µg/mL''' | |'''[DNA] in µg/mL''' | ||
|'''A260/A280''' | |'''A260/A280''' | ||
|- | |- | ||
- | |||
|D159 | |D159 | ||
+ | |EnvZ* | ||
|10 µg/mL | |10 µg/mL | ||
|1.35 | |1.35 | ||
|- | |- | ||
- | |||
|D116 | |D116 | ||
+ | |pSB1A2 | ||
|17 µg/mL | |17 µg/mL | ||
|1.02 | |1.02 | ||
Line 348: | Line 351: | ||
*transformation of TOP10 competent cells with 5 µL of ligation product | *transformation of TOP10 competent cells with 5 µL of ligation product | ||
*spreading on LB plates + ampicilline and incubation overnight at 37°C | *spreading on LB plates + ampicilline and incubation overnight at 37°C | ||
+ | |||
+ | |||
='''Miniprep and stock glycerolof New Biobrick'''= | ='''Miniprep and stock glycerolof New Biobrick'''= | ||
Line 353: | Line 358: | ||
*[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]] | *[[Team:Paris/Notebook/Protocols#Glycerol stocks| Protocol stocks]] | ||
*[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol miniprep]] | *[[Team:Paris/Notebook/Protocols#Minipreps (Kit_Qiagen)| Protocol miniprep]] | ||
- | |||
- | |||
{|border="1" style="text-align: center" | {|border="1" style="text-align: center" | ||
|'''Miniprep''' | |'''Miniprep''' | ||
Line 364: | Line 367: | ||
|MP101.1 | |MP101.1 | ||
|S109.1 | |S109.1 | ||
- | |rowspan="2"| | + | |rowspan="2"|Amp |
|rowspan="2"| J23101 | |rowspan="2"| J23101 | ||
|rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>constitutive promotor | |rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>constitutive promotor | ||
Line 373: | Line 376: | ||
|MP101.1 | |MP101.1 | ||
|S109.1 | |S109.1 | ||
- | |rowspan="2"| | + | |rowspan="2"|Amp |
|rowspan="2"| J23101 | |rowspan="2"| J23101 | ||
|rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>constitutive promotor | |rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>constitutive promotor | ||
Line 382: | Line 385: | ||
|MP104.1 | |MP104.1 | ||
|S111.1 | |S111.1 | ||
- | |rowspan="2"| | + | |rowspan="2"|Amp |
|rowspan="2"| R0040 | |rowspan="2"| R0040 | ||
|rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>ptetR repressible | |rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>ptetR repressible | ||
Line 391: | Line 394: | ||
|MP104.1 | |MP104.1 | ||
|S111.1 | |S111.1 | ||
- | |rowspan="2"| | + | |rowspan="2"|Amp |
|rowspan="2"| R0040 | |rowspan="2"| R0040 | ||
|rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>ptetR repressible | |rowspan="2"| [[Image:Part_icon_regulatory.png]]<br>ptetR repressible | ||
Line 418: | Line 421: | ||
|MP143 | |MP143 | ||
|S157 | |S157 | ||
- | | | + | |Amp |
|E0240 (in pSB1A2) | |E0240 (in pSB1A2) | ||
|[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>RBS GFP dbl term | |[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>RBS GFP dbl term | ||
Line 424: | Line 427: | ||
|MP1151 | |MP1151 | ||
|S150 | |S150 | ||
- | | | + | |Amp |
|L122 <br>D107 (BV) - D130 (BI) | |L122 <br>D107 (BV) - D130 (BI) | ||
|[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>RBS-lasI - ECFP | |[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>RBS-lasI - ECFP | ||
Line 430: | Line 433: | ||
|MP157 | |MP157 | ||
|S156 | |S156 | ||
- | | | + | |Kan |
|L138 (E0240 in pSB3K3) | |L138 (E0240 in pSB3K3) | ||
|[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>gfp generator | |[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]]<br>gfp generator | ||
Line 448: | Line 451: | ||
|MP171 | |MP171 | ||
|S171 | |S171 | ||
- | | | + | |Amp |
|L167 <br>D181 (BV) - D184 (BI) | |L167 <br>D181 (BV) - D184 (BI) | ||
|[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_regulatory.png]]<br>gfp generator - pTet | |[[Image:Icon_rbs.png]][[Image:Icon_reporter.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_terminator.png]][[Image:Part_icon_regulatory.png]]<br>gfp generator - pTet | ||
|} | |} | ||
+ | |||
+ | |||
='''Construction of pFlhB - mRFP Tripart (LVA+)'''= | ='''Construction of pFlhB - mRFP Tripart (LVA+)'''= | ||
Line 512: | Line 517: | ||
|colspan="2"| | |colspan="2"| | ||
|} | |} | ||
+ | |||
='''Screening of the cloning of pFlgA-GFP Generator'''= | ='''Screening of the cloning of pFlgA-GFP Generator'''= | ||
Line 589: | Line 595: | ||
FlgA-GFP generator | FlgA-GFP generator | ||
|} | |} | ||
+ | |||
='''Construction for Synchronisation'''= | ='''Construction for Synchronisation'''= |
Latest revision as of 17:59, 11 September 2008
Extraction of EnvZ* and OmpR* from E. coli genomeName of the PCR
ProtocolProtocol
PCR Programme
ResutsElectrophoresis settings
Results of the electrophoresis
Conclusion : All the PCR worked perfectly well ! Cleaning of the PCR productsThe cleaned PCR products are stored in the freezer overnight.
PCR Promoters and Genes FlhDC/FliAPCR Promoters FlhDC and Gene
Program: Gradient Vf=20µL PCR Promoters FliA
Program: promoter Vf=50µL PCR mutagenesis FliA
Program: PCRFliA1' Program: PCRFliA2 Program: PCRFliA3
Cloning of EnvZ*Concentration measurement by Biophotometer
Ligation
Miniprep and stock glycerolof New Biobrick
Construction of pFlhB - mRFP Tripart (LVA+)Aim : Construction of "pFlhB-RBS-mRFP-dbl ter" (pFlhB-I732078)
DigestionDigestion
Gel Verification
Screening of the cloning of pFlgA-GFP GeneratorElectrophoresis
Minipreps and glycerol stock
Construction for SynchronisationResults of the transformation we did yesterday
|